Naprosyn (Naproxen)

Naproxen, the active ingredient in Naprosyn, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It reduces pain, inflammation and fever in adults and is commonly prescribed for musculoskeletal conditions. It is indicated for short‑term management of acute pain and chronic inflammatory disorders, and is available in standard tablet strengths for convenient dosing.

GNH USA supplies Naprosyn as a licensed, GDP‑compliant international pharmaceutical supplier, providing quality‑assured medicines to hospitals, pharmacies and clinics worldwide through regulated import‑export channels and robust cold‑chain logistics where required.

Naprosyn (naproxen) is an NSAID that acts on inflammatory pathways to relieve various painful and inflammatory conditions.

- Pain: provides relief of mild to moderate acute or chronic pain. - Inflammation: reduces swelling and redness associated with inflammatory processes. - Arthritis: alleviates joint pain and stiffness in osteoarthritis and rheumatoid arthritis. - Dysmenorrhea: eases menstrual cramps and associated discomfort. - Fever: lowers elevated body temperature in febrile states.

Adverse reactions may occur with naproxen therapy and are categorized by frequency and severity.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or heartburn. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Rash or mild skin irritation. - Edema: peripheral swelling. - Elevated blood pressure.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Cardiovascular events such as myocardial infarction or stroke. - Renal impairment or acute kidney injury. - Severe skin reactions (e.g., Stevens‑Johnson syndrome). - Hepatotoxicity: elevated liver enzymes. - Anaphylaxis or severe hypersensitivity reactions.

Before initiating naproxen therapy, clinicians should evaluate patient‑specific risk factors and follow safety guidelines.

- Assess renal function: evaluate kidney health prior to use. - Monitor gastrointestinal risk: avoid in patients with active ulcers or a history of GI bleeding. - Check cardiovascular status: use cautiously in individuals with heart disease or stroke risk. - Avoid concurrent anticoagulants: increased potential for bleeding. - Pregnancy and lactation: consult a healthcare provider before use. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Naproxen may interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened bleeding risk. - Selective COX‑2 inhibitors: additive renal and cardiovascular toxicity. - Methotrexate: increased plasma concentrations.

Moderate Interactions (Monitor Closely): - ACE inhibitors and diuretics: possible reduction in renal function. - Lithium: may raise serum lithium levels. - SSRIs or SNRIs: modest increase in bleeding tendency.